One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Accesshttps://doi.org/10.1182/blood.v130.suppl_1.3155.3155
Copy DOI Journal: Blood |  Publication Date: Jun 25, 2021 |
Affiliation: Prince of Wales Hospital, Peter MacCallum Cancer Centre, University of Pennsylvania, Center for HIV and Hepatogastroenterology, Stiftung Oskar Helene Heim, Rabin Medical Center, Tel Aviv University, Vall d'Hebron Hospital Universitari, Institut Català d'Oncologia, Guy's Hospital, Janssen (United States), Janssen (United Kingdom), University Hospital HeidelbergA Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Siltuximab (Anti IL-6 Monoclonal Antibody) in Patients with High-Risk Smoldering Multiple Myeloma
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
